Topical α-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?
Del Rosso, J. Q. (2017). Topical α-agonist therapy for persistent facial erythema of rosacea and the addition of oxmetazoline to the treatment armamentarium: Where are we now? Journal of Clinical & Aesthetic Dermatology, 10(7), 28-32.
The original material can be found here: http://jcadonline.com/topical-alpha-agonist-therapy-for-persistent-facial-erythema-of-rosacea-and-the-addition-of-oxmetazoline-to-the-treatment-armamentarium-where-are-we-now/